Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals

NCT06101641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2024-11-12

No results posted yet for this study

Summary

The aim of this study was to determine the effect of shellac nail polish application on pulse oximetry measurements in healthy subjects. This study was planned as a prospective, self-controlled clinical research to determine the effect of shellac nail polish application on SpO2 and pulse values in healthy people. The population of the study will consist of women who had shellac nail polish application in a private beauty centre between June 2023 and December 2023. The minimum required sample size was calculated as 162 in G\*Power (3.1.9.2) programme (α=0.05 (two-way), 1-β=0.95). The data will be collected with the data collection form prepared in line with the literature. Firstly, the personal information of the participants will be recorded in the data collection form. The middle finger of the left hand of each participant will be the treatment group and the little finger will be the control group. After the shellac nail polish is applied to the middle finger of the left hand, SpO2 and pulse values will be measured simultaneously with a pulse oximeter from the left hand middle finger and little finger of the participant and recorded on the data form. The data obtained from the study will be analysed using SPSS (Statistical Package for Social Sciences) for Windows 26.0 software.

Conditions

  • Healthy Individuals
  • Shellac Nail Polish
  • Oxygen Saturation
  • Nursing
  • Perioperative Care

Interventions

OTHER

Shellac nail polish application

The middle finger of the left hand of each participant will be the experimental group and the little finger will be the control group. After the shellac nail polish is applied to the middle finger of the left hand, SpO2 and pulse values will be measured by pulse oximetry from the left hand middle finger and little finger of the participant

Sponsors & Collaborators

  • Mersin University

    collaborator OTHER
  • Necmettin Erbakan University

    collaborator OTHER
  • Mustafa Kemal University

    collaborator OTHER
  • Tarsus University

    lead OTHER

Principal Investigators

  • Gülay Altun Uğraş, Assoc. Dr. · Mersin University

  • SERPİL YÜKSEL, Assoc.Dr. · NECMETTİN ERBEKAN UNIVERSITY

  • AYŞENUR SERBEST BAZ · Mustafa Kemal University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2024-07-30
Completion
2024-10-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06101641 on ClinicalTrials.gov